ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report (this page) | Apr 20, 2017 | $720,000 | Replaced |
| 1st Quarter - Amendment | Jul 20, 2017 | $720,000 | Yes |
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Taxation Issues Related to Opioid Pharmaceuticals. User Fee Programs.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER BOWLIN | — |
| MICHAEL BRZICA | — |
| KATHRYN LEE ANDERSON CHADWICK | — |
| CHRISTIAN OMAR CRUZ | — |
| CHESTER DAVIS | — |
| JEFFREY FRANCER New | — |
| DAVID R. GAUGH New | — |
| ERIK C KOMENDANT New | Legislative Director, Rep. Jason Altmire; Legislative Correspondent/Legislative Assistant, Rep. Zoe Lofgren |
| HEIDI WILSON | — |
Copyright/Patent/Trademark CPT
Inter Partes Review (IPR) process. Patent Settlements.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER BOWLIN | — |
| MICHAEL BRZICA | — |
| KATHRYN LEE ANDERSON CHADWICK | — |
| CHRISTIAN OMAR CRUZ | — |
| THOMAS JAMES GARRIGAN | — |
| ERIK C KOMENDANT New | Legislative Director, Rep. Jason Altmire; Legislative Correspondent/Legislative Assistant, Rep. Zoe Lofgren |
| HEIDI WILSON | — |
Trade (domestic/foreign) TRD
Trans-Pacific Partnership (TPP). Transatlantic Trade and Investment Partnership (TTIP). Biologic Exclusivity. USTR Confirmation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER BOWLIN | — |
| MICHAEL BRZICA | — |
| KATHRYN LEE ANDERSON CHADWICK | — |
| CHRISTIAN OMAR CRUZ | — |
| JEFFREY FRANCER New | — |
| ERIK C KOMENDANT New | Legislative Director, Rep. Jason Altmire; Legislative Correspondent/Legislative Assistant, Rep. Zoe Lofgren |
| HEIDI WILSON | — |
Medicare/Medicaid MMM
Medicare Part D Program and Generic Drugs. Medicare reimbursement for biosimilars. Medicaid Rebate Penalty. Medicare Part D Low Income Subsidy (LIS) Program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER BOWLIN | — |
| MICHAEL BRZICA | — |
| KATHRYN LEE ANDERSON CHADWICK | — |
| CHRISTIAN OMAR CRUZ | — |
| CHESTER DAVIS | — |
| THOMAS JAMES GARRIGAN | — |
| ERIK C KOMENDANT New | Legislative Director, Rep. Jason Altmire; Legislative Correspondent/Legislative Assistant, Rep. Zoe Lofgren |
| CHRISTINE SIMMON | — |
| HEIDI WILSON | — |
Budget/Appropriations BUD
FDA Funding. S.2956: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017. H.R.5054: Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2017. S.Con.Res.3: A concurrent resolution setting forth the congressional budget for the United States Government for fiscal year 2017 and setting forth the appropriate budgetary levels for fiscal years 2018 through 2026.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER BOWLIN | — |
| MICHAEL BRZICA | — |
| KATHRYN LEE ANDERSON CHADWICK | — |
| CHRISTIAN OMAR CRUZ | — |
| JEFFREY FRANCER New | — |
| DAVID R. GAUGH New | — |
| ERIK C KOMENDANT New | Legislative Director, Rep. Jason Altmire; Legislative Correspondent/Legislative Assistant, Rep. Zoe Lofgren |
| HEIDI WILSON | — |
Pharmacy PHA
Implementation of Food and Drug Administration Safety and Innovation Act (FDASIA) and Generic Drug User Fee Amendments (GDUFA). Biosimilar User Fee Act (BsUFA). Labeling of Generic Drugs. Biosimilars Naming. Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products. Prescription Drug Costs. H.R.2841: FAST Generics Act of 2015. H.R.1314: Bipartisan Budget Act of 2015. Risk Evaluation and Mitigation Strategies (REMS). Biologic Exclusivity. Biologics Price Competition and Innovation Act (BPCIA). Pharmaceutical Exclusivity. S.3056: CREATES Act of 2016. H.R.6043/S.3335: Fair Accountability and Innovative Research Drug Pricing Act of 2016. S.297: Increasing Competition in Pharmaceuticals Act. H.R.749: Lower Drug Costs through Competition Act. Drug Importation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTOPHER BOWLIN | — |
| MICHAEL BRZICA | — |
| KATHRYN LEE ANDERSON CHADWICK | — |
| CHRISTIAN OMAR CRUZ | — |
| CHESTER DAVIS | — |
| JEFFREY FRANCER New | — |
| THOMAS JAMES GARRIGAN | — |
| DAVID R. GAUGH New | — |
| ERIK C KOMENDANT New | Legislative Director, Rep. Jason Altmire; Legislative Correspondent/Legislative Assistant, Rep. Zoe Lofgren |
| CHRISTINE SIMMON | — |
| HEIDI WILSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.